AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 MAR 15 - (NewsRx.com & NewsRx.net) -- With the completion of a study by researchers at the University of Washington, the relationship between hormone replacement therapy and myocardial infarction is a little clearer.
The study, published in the February 21, 2001, edition of the Journal of the American Medical Association, shows a possible link between the presence of a genetic variant associated with blood clotting and the risk of non-fatal myocardial infarction (MI) in hypertensive women taking hormone replacement therapy (HRT).
The lead author of the study is Dr. Bruce M. Psaty, a professor of medicine, epidemiology and health services and co-director of the UW's Cardiovascular Health Research Unit. He and his co-authors studied the prothrombin gene in a case-control study conducted at Group Health Cooperative, a health system based in Seattle, Washington. Prothrombin (factor II) is a protein essential for the clotting of blood. The prothrombin gene variant (G20210A) occurs in 2% to 4% of the population and increases the risk of blood clots in the legs.
The investigators studied 232 post-menopausal women who suffered a first non-fatal MI between 1995 and 1998. The control group included 723 postmenopausal women matched to the cases by age, calendar year of the cardiac event, and hypertension status. In women with hypertension, the effects of HRT on MI risk depended on the prothrombin gene. Among women who did not have the genetic variant, HRT users had a slightly lower risk of MI than women who did not use HRT. Among women with the prothrombin gene variant, however, HRT users had an eight-fold higher risk of MI than women who did not use HRT. Although the number of women with the prothrombin variant was small, the MI risk associated with HRT use differed markedly between those with and ...
Source: HighBeam Research, Possible Drug-Gene Interaction Associated With Heart Attacks In...